VERTEX PHARMACEUTICALS INC / MA Payments to Acquire Other Investments
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Payments to Acquire Other Investments of $37.99 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherInvestments · last filed 2021-11-03
- 2021-09-30: Payments to Acquire Other Investments 9 month $37.99M.
- 2020-09-30: Payments to Acquire Other Investments 9 month $19.33M.
- 2016-09-30: Payments to Acquire Other Investments 9 month $20.00M.
- 2015-09-30: Payments to Acquire Other Investments 9 month $0.00.
| Period end | Payments to Acquire Other Investments 9 month |
|---|---|
| 2021-09-30 | $37.99M 10-Q · filed 2021-11-03 |
| 2020-09-30 | $19.33M 10-Q · filed 2021-11-03 |
| 2016-09-30 | $20.00M 10-Q · filed 2016-10-31 |
| 2015-09-30 | $0.00 10-Q · filed 2016-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |